Th1-to Th2 shift of HSP65 responses and atherogenesis

HSP65 反应的 Th1 向 Th2 转变和动脉粥样硬化形成

基本信息

  • 批准号:
    6945782
  • 负责人:
  • 金额:
    $ 28.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2008-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant Infections caused by the intracellular organisms, Chlamydia pneumoniae, Mycobacterium sp. and/or Helicobacter pylori, have been implicated as co-risk factors in atherosclerosis, but their exact roles in disease progression remain controversial. We propose to characterize the immunological shifts in atherosclerosis that would be accelerated by the infections. Type 1 helper T lymphocyte- (Thl-) immunity activates local macrophages (MQ) that kill the intracellular bacteria and also potentially damage endothelial tissue, which could initiate lesions at the early stages. Previous studies suggest that splenic prostaglandin E2-releasing MQ (PGE2-MQ) levels are increased with the progression of atherosclerosis and in infections. Since PGE2 is a powerful inducer of the Thl to Th2 immune shift, PGE2-MQ could make a major contribution to the pathogenesis of chronic stages of atherosclerosis. In this. regard, much attention has been directed to mycobacterial 65kDa-heat shock protein (HSP65), an immunodominant antigen having cross-reactivity with other bacterial and mammalian HSPs. The Thl-to-Th2 shifts generate antibodies against HSP65 that potentially attack arteries through antigenic mimicry. Although the development of the Thl cells mediates resistance to tuberculosis, it remains unclear whether HSP65-specific Thl responses are also pro-atherogenic. Our goals are to understand the respective atherogenic roles of HSP65-specific Thl and Th2 responses as well as the mechanism of the shifts. We will employ hypercholesterolemic apolipoprotein E-knockout (apoE-KO) mice and wild type (WT) controls immunized with HSP65 or heat-killed (HK) M. bovis BCG containing HSP65. We hypothesize that HSP65-specific Th2 responses will enhance atherogenic lesion development in apoE-KO mice. We will determine if immunization with HSP65 and chitin, a Thl adjuvant, or alum, a Th2 adjuvant, will have an effect on atherogenic lesion development in apoE-KO mice. We will further determine if adoptive transfer of HSP65- specific Thl cells or Th2 cells will have an effect on atherogenic lesion development in apoE-KO recipients. Treatment of mice with 89Sr destroys PGE2-MQ precursors in the bone marrow and suppresses the formation of splenic PGE2-MG. We hypothesize that this will also result in retention of the Thl responses without a shift to a Th2 response. Mice treated with 89Srwill receive HK-BCG immunization to determine the effect on response to HSP65. Finally, we will determine if transfusion of fit-1 +marrow cells from HK-BCG treated WT donors will restore the Thl-to-Th2 shifts in 89Sr-treated WT recipients.
描述(由申请人提供)

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Persistent inactivation of macrophage cyclooxygenase-2 in mycobacterial pulmonary inflammation.
分枝杆菌肺部炎症中巨噬细胞环氧合酶-2 的持续失活。
Role of PPARγ in COX-2 activation in mycobacterial pulmonary inflammation.
PPARγ 在分枝杆菌肺部炎症中 COX-2 激活中的作用。
  • DOI:
    10.1007/s10753-012-9486-x
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Kogiso,Mari;Shinohara,Tsutomu;Dorey,CKathleen;Shibata,Yoshimi
  • 通讯作者:
    Shibata,Yoshimi
Heat-killed BCG induces biphasic cyclooxygenase 2+ splenic macrophage formation--role of IL-10 and bone marrow precursors.
热灭活的 BCG 诱导双相环氧合酶 2 脾巨噬细胞形成——IL-10 和骨髓前体的作用。
  • DOI:
    10.1189/jlb.1205737
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Shibata,Yoshimi;Gabbard,Jon;Yamashita,Makiko;Tsuji,Shoutaro;Smith,Mike;Nishiyama,Akihito;Henriksen,RuthAnn;Myrvik,QuentinN
  • 通讯作者:
    Myrvik,QuentinN
Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG.
COX-2 在吞噬热灭活牛分枝杆菌 BCG 的巨噬细胞中的差异亚细胞定位。
  • DOI:
    10.1152/ajpcell.00346.2006
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yamashita,Makiko;Tsuji,Shoutaro;Nishiyama,Akihito;Myrvik,QuentinN;Henriksen,RuthAnn;Shibata,Yoshimi
  • 通讯作者:
    Shibata,Yoshimi
Dietary Chitin Particles Called Mimetic Fungi Ameliorate Colitis in Toll-Like Receptor 2/CD14- and Sex-Dependent Manners.
称为模拟真菌的膳食几丁质颗粒可通过 Toll 样受体 2/CD14 和性别依赖性方式改善结肠炎。
  • DOI:
    10.1128/iai.00006-19
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Louis,Patricia;Mercer,Brian;Cirone,AikoM;Johnston,Christina;Lee,ZacharyJ;Esiobu,Nwadiuto;Li,Zhongwei;Wei,Jianning;Dorey,CKathleen;Shibata,Yoshimi;Nan,Changlong
  • 通讯作者:
    Nan,Changlong
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIMI SHIBATA其他文献

YOSHIMI SHIBATA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIMI SHIBATA', 18)}}的其他基金

Dietary anti-inflammatory chitin in colitis
结肠炎中膳食抗炎甲壳素
  • 批准号:
    8686392
  • 财政年份:
    2014
  • 资助金额:
    $ 28.1万
  • 项目类别:
Th1-to Th2 shift of HSP65 responses and atherogenesis
HSP65 反应的 Th1 向 Th2 转变和动脉粥样硬化形成
  • 批准号:
    6802388
  • 财政年份:
    2002
  • 资助金额:
    $ 28.1万
  • 项目类别:
Th1-to Th2 shift of HSP65 responses and atherogenesis
HSP65 反应的 Th1 向 Th2 转变和动脉粥样硬化形成
  • 批准号:
    6663819
  • 财政年份:
    2002
  • 资助金额:
    $ 28.1万
  • 项目类别:
Th1-to Th2 shift of HSP65 responses and atherogenesis
HSP65 反应的 Th1 向 Th2 转变和动脉粥样硬化形成
  • 批准号:
    6560070
  • 财政年份:
    2002
  • 资助金额:
    $ 28.1万
  • 项目类别:

相似国自然基金

卡路里限制的T细胞糖脂代谢重塑机制及网络调控
  • 批准号:
    91957111
  • 批准年份:
    2019
  • 资助金额:
    80.0 万元
  • 项目类别:
    重大研究计划
高尿酸血症促进动脉粥样硬化机制探讨
  • 批准号:
    81170251
  • 批准年份:
    2011
  • 资助金额:
    14.0 万元
  • 项目类别:
    面上项目
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
  • 批准号:
    81000086
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
  • 批准号:
    81070247
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
  • 批准号:
    30971216
  • 批准年份:
    2009
  • 资助金额:
    31.0 万元
  • 项目类别:
    面上项目
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
  • 批准号:
    30871040
  • 批准年份:
    2008
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
  • 批准号:
    10750690
  • 财政年份:
    2024
  • 资助金额:
    $ 28.1万
  • 项目类别:
Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH)
秋水仙碱用于预防急性脑出血后血管事件(CoVasc-ICH)
  • 批准号:
    485530
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Operating Grants
Identifying the Role of Sex Hormones in Carotid Atherosclerotic Plaque Instability
确定性激素在颈动脉粥样硬化斑块不稳定中的作用
  • 批准号:
    494557
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Operating Grants
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
    Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
Diabetic Memory in Hematopoietic Stem Cells
造血干细胞的糖尿病记忆
  • 批准号:
    10655742
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
  • 批准号:
    10722515
  • 财政年份:
    2023
  • 资助金额:
    $ 28.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了